Before the pandemic shifted and altered much of the life science industry “business as usual” plan, we’ve been on a mission to scale up digital technology adaptation and integrate it within our operations.  From creating a piloted project of a  “digital” lab, we’re focusing on maximizing the use of blending technologies and scientific expertise from remote locations to serve our global client footprint better.

Next, we’ve accelerated much of our RWE/RWD integration tools for projects within the infectious disease space for unknown and little-known diseases we’ve yet to uncover.  The ability to deploy a cocktail of tools that can harness the option of even supporting paper-based documentation systems to collate it into analytics has been successfully realized.